The preliminary study was conducted by scientists from the Spallanzani Institute in Italy and Gamaleya Institute in Moscow, the developer of Sputnik V vaccine.
A small preliminary laboratory study has shown that levels of Omicron-neutralising antibodies of people vaccinated with Russia's Sputnik V vaccine did not decline as much as of those who had Pfizer shots
A small preliminary laboratory study has shown that levels of Omicron-neutralising antibodies of people vaccinated with Russia's Sputnik V vaccine did not decline as much as of those who had Pfizer shots.